Haleon (NYSE:HLN – Get Free Report) and Mannatech (NASDAQ:MTEX – Get Free Report) are both consumer staples companies, but which is the better stock? We will contrast the two companies based on the strength of their profitability, institutional ownership, valuation, earnings, dividends, analyst recommendations and risk.
Analyst Ratings
This is a summary of current ratings for Haleon and Mannatech, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Haleon | 1 | 5 | 2 | 2 | 2.50 |
| Mannatech | 1 | 0 | 0 | 0 | 1.00 |
Haleon presently has a consensus price target of $4.90, indicating a potential downside of 46.04%. Given Haleon’s stronger consensus rating and higher possible upside, equities analysts clearly believe Haleon is more favorable than Mannatech.
Institutional & Insider Ownership
Profitability
This table compares Haleon and Mannatech’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Haleon | N/A | N/A | N/A |
| Mannatech | -0.41% | -2,383.34% | -1.48% |
Risk & Volatility
Haleon has a beta of 0.15, suggesting that its share price is 85% less volatile than the S&P 500. Comparatively, Mannatech has a beta of 0.62, suggesting that its share price is 38% less volatile than the S&P 500.
Earnings and Valuation
This table compares Haleon and Mannatech”s gross revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Haleon | $14.54 billion | 2.74 | $2.20 billion | $0.39 | 23.28 |
| Mannatech | $108.04 million | 0.05 | -$15.21 million | ($0.31) | -8.26 |
Haleon has higher revenue and earnings than Mannatech. Mannatech is trading at a lower price-to-earnings ratio than Haleon, indicating that it is currently the more affordable of the two stocks.
Summary
Haleon beats Mannatech on 11 of the 14 factors compared between the two stocks.
About Haleon
Haleon plc is a global consumer healthcare company that develops and sells nonprescription health products. Its portfolio spans oral health, pain relief, vitamins and supplements, respiratory health, digestive health, and therapeutic skin care. Its brands include Sensodyne, parodontax and Polident in oral care; Advil, Panadol and Voltaren for pain relief; and Centrum, Emergen-C and Theraflu in supplements and respiratory care. Haleon sells its products in markets around the world. Haleon became an independent public company in 2022 after separating from GSK.
About Mannatech
Mannatech, Incorporated is a wellness company that develops and sells nutritional supplements, skincare products and other personal-care items. Its product portfolio includes supplements featuring plant-based ingredients and products marketed under brands such as Ambrotose and PhytoMatrix. The company distributes its products primarily through a network of independent sales associates, supported by online sales channels. Mannatech was founded in 1994 and serves customers in the United States and international markets.
Receive News & Ratings for Haleon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Haleon and related companies with MarketBeat.com's FREE daily email newsletter.
